MedTrace Logo

A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence

NCT00345332 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2017-07-11

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine how effective Botox is in reducing the amount of urine leaked and which dose of Botox is more effective and safe in those who have urinary urge incontinence.

Conditions

Interventions

DRUG

Botox

Injected

DRUG

Placebo

Injected

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Michael K Flynn, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00345332 on ClinicalTrials.gov